In no way am I trying to down-ramp, or bring doubt to what will likely be a significant event for Imugene...However, has anyone else had the following thought...
If the onCARlytics (CF33-CD19t oncolytic virus) results are so significant and 'paradigm shifting' - why are they just a abstract/poster readout? Wouldn't they warrant their own presentation/session/seminar?
There are some 850+ poster presentations - are we saying that Abstract #368 is more significant than the results that are actually being 'presented' and formally delivered? If so, why is it given the same time as the other abstracts - or is it a mandate for preclinical/trial results to be abstracts only?
Apologies in advance if what I have stated/asked is ignorant - I've never been to any sort of health/medical conference!
Outstanding news, page-27
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |